PRESS RELEASE
News
-
-
PRESS RELEASE
TCMA and the Government of Saskatchewan, Canada sign MOU accelerating toward Net Zero with knowledge transfer and advanced low carbon technologies
Thai Cement Manufacturers Association (TCMA) and the Government of Saskatchewan, Canada signed an MOU to accelerate CCUS technology adoption for net-zero cement industry by 2050 -
PRESS RELEASE
Bausch Health's OraPharma Introduces "OraTalks," a New Podcast Bringing Bold Conversations to Dentistry
OraTalks, a new podcast by Bausch Health's OraPharma, features industry thought leader Melissa K. Turner hosting candid conversations with leading clinicians on latest trends in dentistry. Episodes launch Sep 29 on major platforms -
-
-
PRESS RELEASE
Eightco Holdings Inc. (ORBS) Announces 16.9 Million Verified World Humans, Adding 1.9 Million Since Launching Worldcoin Treasury Just 3 Weeks Ago
Eightco Holdings Inc. (ORBS) unveils 'Power of 8' initiative, adding 1.9 million verified humans to reach 16.9 million since Worldcoin Treasury launch -
PRESS RELEASE
Silver X Mining Announces Closing Of Private Placements For Aggregate Gross Proceeds Of C$21.5 Million
Silver X Mining Corp. announces closing of C$21.5 million financing via 'bought deal' private placement and non-brokered private placement. Company plans to advance operations and exploration in Peru's Nueva Recuperada Silver District -
PRESS RELEASE
Sterling Metals Announces High-Grade Copper Discovery at the Soo Copper Project Intersecting 262.5m of 1.05% CuEq, Including 68.3m of 3.25% CuEq and 9.3m of 19.8% CuEq from Near Surface
Sterling Metals Corp. announces discovery of high-grade copper zone at Soo Copper Project in Batchewana Bay, Ontario, with significant Cu-Au mineralization. Phase 2 drilling reveals highest copper and gold grades to date -
-
PRESS RELEASE
Medicus Pharma Ltd. Receives Positive Feedback From the Food and Drug Adminstration (FDA) Type C Meeting Supporting the Development of Skinject
FDA agrees to 505(b)(2) pathway for Medicus Pharma's Skinject D-MNA to treat BCC, positive Type C meeting feedback, SKNJCT-003 patient recruitment aims, EOP2 request in Q1 2026
